Catalogo Ricerca

Catalogo Ricerca: [57181] Home page macrotipologia

Sfoglia

1 Contributo su Rivista 46798
- 1.1 Articolo in rivista 39316
- 1.1.1 Articolo in rivista - Review 1674
- 1.1.2. Articolo in Rivista - Letter, Note 860
- 1.1.3. Articolo in Rivista - Editorial, Comment, Reply 1151
- 1.1.4. Guidelines, Consensus 111
- 1.1.5. Erratum 193
- 1.2 Recensione in rivista 283
- 1.3 Scheda bibliografica 14
- 1.4 Nota a sentenza 0
- 1.5 Abstract in rivista 3184
- 1.6 Traduzione in rivista 12

2 Contributo in Volume 3181

3 Libro 780
- 3.1 Monografia o trattato scientifico 644
- 3.2 Concordanza 0
- 3.3 Indice 5
- 3.4 Bibliografia 12
- 3.5 Edizione critica 24
- 3.6 Pubblicazione di fonti inedite 5
- 3.7 Commento scientifico 13
- 3.8 Traduzione di libro 77

4 Contributo in Atti di Convegno (Proceeding) 5689
- 4.1 Contributo in Atti di convegno 2260
- 4.2 Abstract in Atti di convegno 3018
- 4.3 Poster 411

5 Altro 112
- 5.01 Preprint 12
- 5.02 Composizione 0
- 5.03 Disegno 0
- 5.04 Design 0
- 5.05 Performance 3
- 5.06 Esposizione 0
- 5.07 Mostra 1
- 5.08 Manufatto 1
- 5.09 Prototipo d'arte e relativi progetti 0
- 5.10 Cartografia 0
- 5.11 Banca dati 1
- 5.12 Software 12
- 5.13 Altro 82
- 5.14 Progetto architettonico 0
- 5.15 Articolo su portale o periodico 0

6 Brevetti 176
- 6.1 Brevetto 176

7 Curatele 198
- 7.1 Curatela 198

8 Tesi di dottorato 247
- 8.1 Tesi di dottorato 247

Prodotti recenti

Increased prevalence of morphometric vertebral fractures in patients with hypercalcitoninemia due to medullary thyroid carcinoma

Context: Calcitonin is a well-established biomarker of medullary thyroid cancer (MTC) but it is also known to exert distinct effects on bone metabolism. Previous studies evaluating calcitonin actions on skeletal health have yielded inconsistent results regarding its protective or deleterious role. To date, the impact of chronic hypercalcitoninemia, typically observed in patients with MTC, on skeletal fragility complications, particularly vertebral fractures (VFs), has not been investigated. D...

CCM-ITALUNG2 pilot on lung cancer screening in Italy: recruitment, integration with smoking cessation and baseline results

Background: The CCM-ITALUNG2 pilot was implemented to evaluate the feasibility of an organized lung cancer (LC) screening programme in five Italian centres. Methods: The screening pathway included invitation, recruitment, referral to Smoking Cessation Services (SCSs), and use of the Lung-RADS score for low-dose CT reading. Dedicated screening operators followed up participants from recruitment through the clinical follow-up established by multidisciplinary teams. Eligibility criteria included...

Prognostic Impact of Osteopenia in Patients with Resectable Esophageal Adenocarcinoma: A Retrospective Study

Introduction. Osteopenia, marked by low bone mineral density, is a sign of patient frailty and has been linked to poor survival in patients with esophageal squamous cell carcinoma. However, its impact on overall survival (OS) and disease-free survival (DFS) in patients with esophageal adenocarcinoma is still unclear. Aim. Our aim was to assess the impact of osteopenia on long-term survival in patients with resectable esophageal adenocarcinoma. Methods. This was a retrospective study (January ...

Sex Differences in Procedural Characteristics and Clinical Outcomes Among Patients Undergoing Bifurcation PCI

Background and Objectives: The risk profiles, procedural characteristics, and clinical outcomes for women undergoing bifurcation percutaneous coronary intervention (PCI) are not well defined compared to those in men. Methods: COronary BIfurcation Stenting III (COBIS III) is a multicenter, real-world registry of 2,648 patients with bifurcation lesions treated with second-generation drug-eluting stents. We compared the angiographic and procedural characteristics and clinical outcomes based on s...

Cell-Free Therapies for Chronic Pain: The Rise of the Mesenchymal Stem Cell Secretome

Chronic pain is a pervasive global health issue that significantly impairs quality of life and remains inadequately managed by current therapeutic options. Traditional pharmacological treatments often offer limited relief and are associated with significant side effects, highlighting the urgent need for safer and more effective alternatives. Among emerging strategies, mesenchymal stem cell (MSC)-derived secretome, an acellular product composed of bioactive molecules such as cytokines, growth ...

Scopri

Accesso al fulltext

no fulltext49378
open4284
reserved3382
partially open97
embargoed40